HR
ABMD

Howe & Rusling’s Abiomed Inc ABMD Stock Holding History

Howe & Rusling’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,235
Closed -$322K – 879
2019
Q2 		$322K Buy
+1,235
New +$328K 0.06% 154
2019
Q1 		– Sell
-26
Closed -$8K – 919
2018
Q4 		$8K Hold
26
– – ﹤0.01% 479
2018
Q3 		$12K Buy
+26
New +$10.2K ﹤0.01% 476
2015
Q4 		– Sell
-15
Closed -$1K – 1094
2015
Q3 		$1K Hold
15
– – ﹤0.01% 974
2015
Q2 		$1K Buy
+15
New +$997 ﹤0.01% 996

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Howe & Rusling's ABMD Position: Q3 2019 in Review

Howe & Rusling sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 1,235 shares — an estimated $322K sold.

Howe & Rusling first reported a position in ABMD in Q2 2015 and held it in 5 quarters. The position peaked at $322K in Q2 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Howe & Rusling reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Howe & Rusling sold 1,235 Abiomed Inc shares in Q3 2019, an estimated $322K.
  • Howe & Rusling first reported a position in Abiomed Inc in Q2 2015 and held it in 5 quarters.
  • Howe & Rusling's Abiomed Inc position peaked at $322K in Q2 2019.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Howe & Rusling's 13F filing for Q3 2019, filed 31 Oct 2019.